Immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy for first‐line treatment of advanced non‐small cell lung cancer: a generic protocol

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the effectiveness and toxicity of immune checkpoint inhibitors plus chemotherapy versus chemotherapy or immunotherapy alone as first‐line treatment of advanced non‐small cell lung cancer (NSCLC).

Guardado en:
Detalles Bibliográficos
Publicado en:Cochrane Database Syst Rev
Autores principales: Syn, Nicholas LX, Roudi, Raheleh, Wang, Louis Zizhao, Wang, Lingzhi, Loh, Marie, Huang, Yiqing, Ou, Sai‐Hong Ignatius, Soong, Richie, Drilon, Alexander, Wee, Ian
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons, Ltd 2018
Materias:
Medicine General & Introductory Medical Sciences
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494557/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD013009
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares